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Background and purpose   Experimental models of osteoporosis 
in rabbits are useful to investigate anabolic agents because rabbits 
have an active Haversian remodeling and achieve skeletal maturi-
aty quickly. In this study, an experimental model of osteoporosis 
in rabbits induced by a combination of ovariectomy and glucocor-
ticoid was characterized to provide a useful model for prevention 
and therapy of osteoporosis.
Methods   32 skeletally mature female rabbits were divided 
randomly  into  4  groups:  sham  control,  bilateral  ovariectomy 
(OVX), 1mg/kg/day methylprednisolone (MP) for 8 weeks, and 
OVX in combination with MP. All rabbits were killed 10 weeks 
after surgery. Bone mineral density (BMD) of lumbar spine was 
measured by dual-energy X-ray absorptiometry at baseline, and 
at 6 and 10 weeks postoperatively. Bone microarchitecture and 
mechanical properties of lumbar vertebrae were investigated by 
high-resolution  micro-computed  tomography  and  compression 
test, respectively, after killing. 
Results   Mean BMD of the OVX+MP group at 10 weeks was 
reduced by about 36% from baseline (p < 0.001). Bone microar-
chitecture of lumbar vertebrae in the OVX+MP group indicated 
osteoporosis-associated  deterioration.  There  was  a  statistically 
significant  reduction  in  maximum  load,  stiffness,  and  energy 
absorption capacity of lumbar vertebrae in the OVX+MP group, 
but not in the OVX group, compared to the sham control. In the 
MP group, BMD and some microarchitecture parameters such as 
trabecular thickness and bone volume fraction were reduced. The 
mechanical properties were not statistically significantly different 
from those in the sham control group, however, although a nega-
tive trend was observed.
Interpretation   Osteopenia can be induced experimentally in 
rabbits through a combination of OVX and MP, and can be evalu-
ated by BMD, bone microstructure, and mechanical parameters.

 
As there is no ideal animal model for osteoporosis, since 1994 
the US Food and Drug Administration (FDA) has required 
data from at least two animal species for preclinical evalu-
ation  of  new  experimental  drugs  (Thompson  et  al.  1995). 
Although the ovariectomized rat represents the “gold stan-
dard”  in  experimental  animal  models  for  postmenopausal 
osteoporosis studies (Kalu 1991, Frost and Jee 1992, Lelovas 
et al. 2008), it has several disadvantages, such as the failure to 
achieve true skeletal maturity, the lack a of Haversian system, 
and the low rate of remodeling in cortical bone (Rodgers et al. 
1993, Mosekilde 1995). These conditions limit the use of rats 
for assessment of new treatments for osteoporosis, especially 
bone-forming agents, which require exploration of dynamic 
trabecular and cortical bone remodeling. Thus, it is necessary 
to characterize other experimental animal models for osteopo-
rosis. Rabbits have often been used to study ingrowth of bone 
into implants and bone-implant interfaces (Mori et al. 1997, 
Southard et al. 2000, Cao et al. 2004). Rabbits achieve skeletal 
maturity at 7–8 months, show substantial intracortical remod-
eling, and have a more rapid bone turnover than other rodents 
and even primates (Gilsanz et al. 1988, Newman et al. 1995). 
In spite of these potential advantages, rabbit osteoporosis (OP) 
models have not been widely used and are not fully charac-
terized (Newman et al. 1995, Mori et al. 1997). Castaneda et 
al. (2006, 2008) proposed an experimental model of OP in 
rabbits induced by a combination of ovariectomy (OVX) and 
glucocorticoid administration, but only bone mineral density 
(BMD) was determined. Without the assessment of microar-
chitecture and mechanics of the bone, a more complete skel-
etal characterization of the rabbit model cannot be achieved.
The aim of this study was to further characterize the experi-
mental model of OP in rabbits induced by a combination of 
both  experimental  interventions  (OVX  and  glucocorticoid 
administration). BMD, bone microarchitecture, and mechani-
cal properties were determined for evaluation. Acta Orthopaedica 2010; 81 (3): 396–401  397
Material and methods
Animals
All animal care and experimental procedures were conducted 
with the approval of the Animal Care and Use Committee of 
Fourth Military Medical University, and were in accordance 
with the NIH Guidelines for the Care and Use of Laboratory 
Animals. 32 8-month-old (4.1 ± 0.38 kg body weight), skele-
tally mature, female New Zealand white rabbits were obtained 
from the Animal Center of Fourth Military Medical Univer-
sity. They were housed individually in stainless steel cages in 
a standard animal facility, where the room temperature was 
maintained at 21–24°C with 40–60% relative humidity and a 
12-h light-dark cycle. The light cycle coincided with daylight 
hours. The standard chow (containing 0.8% calcium and 0.5% 
phosphorus) and tap water were available ad libitum. After 
a 10-day quarantine and acclimatization period, the baseline 
BMD of the lumbar vertebrae was measured in all animals. 
Based on the baseline data, the 32 rabbits were then randomly 
divided into 4 groups of 8 rabbits each (a sham control group, 
an OVX group, a methylprednisolone (MP) group, and an 
OVX+MP group). 
Experimental animal model of osteoporosis
A  schedule  of  the  experimental  interventions  is  shown  in 
Figure 1. Briefly, the rabbits were fasted for 24 h prior to sur-
gery. The OVX group and the OVX+MP group received bilat-
eral OVX through a ventral incision under general anesthe-
sia with intramuscular injection of pentobarbital sodium (50 
mg/kg). The sham control group and the MP group received 
sham surgery. All animals were fasted for another 12 h, and 
antibiotic  prophylaxis  with  cefonicid  sodium  (100  mg/kg) 
was administered before and during the 5 days following sur-
gery to minimize any complications. 2 weeks after the sur-
gery, rabbits in the MP group and the OVX+MP group were 
injected intramuscularly with methylprednisolone succinate 
dissolved in 0.9% benzyl alcohol at a dosage of 1 mg/kg/day 
for 8 consecutive weeks; rabbits in the sham control and OVX 
groups were injected with 0.9% benzyl alcohol. Animals were 
weighed and the doses were adjusted on a weekly basis. 
At the end of the above treatment, all animals were killed 
with a lethal dose of pentobarbital sodium. Lumbar vertebrae 
(L3 and L4) were dissected free, placed in sterile saline, and 
stored airtight at –20ºC until examination.
Bone mineral density analysis
BMD of the lumbar spine was measured in vivo with a dual-
energy X-ray absorptiometer (DEXA; Lunar DPX-IQ, Madi-
son, WI) in all rabbits before the surgery; this was repeated 
6 weeks postoperatively and immediately before killing (see 
Figure 1). Specific software for small animals was used. Under 
general anesthesia, each rabbit was fixed in the supine position 
on the stage of the DEXA, and a point located 3 cm below the 
navel was used as the external guide to focus the DEXA pencil 
beam at about L3–L4. Mean absorptiometry values of L3 and 
L4 were calculated.
Micro-CT examination
A cone-beam-type desktop micro-CT system (Explore Locus 
SP, GE Healthcare) was used to quantify structural parameters 
of the lumbar vertebrae. The analytical conditions were 80 kV 
with 80 μA, and the spatial resolution was 14 μm according to 
the protocol of largetube_14 μm_150 min_SS for about 500 
consecutive sections. For all vertebrae, a cylinder region of 
interest (ROI, diameter 3 mm × height 4 mm) was chosen and 
reconstructed  three-dimensionally  using  Micview  software. 
After thresholding, trabecular thickness (Tb.Th), trabecular 
number (Tb.N), trabecular separation (Tb.Sp), bone surface/
bone volume (BS/BV), bone volume/total volume (BV/TV), 
and connectivity density (Conn.D) were determined. All eval-
uations were performed without any knowledge of the experi-
mental identity of the sample.
Mechanical testing
The specimens were thawed before mechanical tests and kept 
moist during all handling and test procedures. Both end-plates 
of the vertebral body were removed using a low-speed preci-
sion diamond saw with continuous irrigation to obtain paral-
lel sections. The spinous, transverse, and articulate processes 
were also removed with the saw. By these procedures, a cen-
tral part of the vertebral body with parallel ends was obtained, 
consisting of a central trabecular core and a compact shell. 
The individual vertebrae were then tested along the longitu-
dinal axis in a materials testing machine (AGS-10kNG; Shi-
madzu Corporation, Japan) at a constant compression speed 
of 1 mm/min. The specimens were loaded to failure and maxi-
mum  load,  displacement,  stiffness,  and  energy  absorption 
capacity were recorded according to the load-displacement 
curves. Maximum load is the force (in N) that a material can 
sustain before failure. Displacement is the ultimate deformity 
before failure (in mm). The slope of the linear portion of the 
load-displacement curve (N/mm) was defined as stiffness. The 
area under the load-displacement curve was defined as energy 
absorption capacity (in mJ).
Figure 1. The experimental schedule and interventions in each group.
OVX: ovariectomy; MP: methylprednisolone; DEXA: dual-energy X-ray 
absorptiometry.
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Statistics
All statistical analyses were performed using commercially 
available software (SPSS version 10.0). Results are expressed 
as mean ± SD. Data from multiple groups were compared 
using one-way analysis of variance (ANOVA), and the signifi-
cance of difference from the control group was determined by 
Dunnett post hoc test. Significant levels of all the tests were 
set at p < 0.05.
Results
All  animals  survived  the  10-week  protocol  and  no  surgi-
cal  complications  or  macroscopic  signs  of  infection  were 
observed. The body weight of the 4 groups of animals ranged 
from 4.1 ± 0.25 to 4.3 ± 0.37 at baseline. Over the course of 
the study, body weight was similar in the experimental ani-
mals and the controls, and between groups (Table 1).
BMD measurements
Compared to the sham control, a significant reduction in BMD 
was seen in the OVX+MP group 6 weeks (p < 0.05) and 10 
weeks (p < 0.001) after surgery, and BMD at the end of the 
experiment was reduced by 36% from baseline. On the other 
hand, the MP group did not show any remarkable changes of 
BMD until the endpoint, in comparison to the control group. 
BMD in the control group and in the OVX group remained 
stable throughout the study (Table 2). 
Bone microarchitecture
No differences in trabecular bone morphology were detected 
between the OVX group and control group (Table 3 and Figure 
2). Rabbits in the MP group had less BV/TV (–17%, p < 0.05) 
compared  to  sham  control  group,  with  thinner  trabeculae 
(–19%, p < 0.05). All structural parameters of the lumbar ver-
tebrae in the OVX+MP group changed relative to the control 
group (Tb.N decreased by 24%, p < 0.05; Tb.Th decreased 
by 33%, p < 0.001; Tb.Sp increased by 58%, p < 0.01; BV/
TV decreased by 39%, p < 0.001; BS/BV increased by 48%, 
p < 0.01; Conn.D. decreased by 35%, p < 0.01). 
Mechanical properties of the lumbar vertebrae
In the OVX+MP group, maximum load was reduced by 39% 
(p < 0.001), stiffness was reduced by 40% (p < 0.01), and 
energy absorption capacity was 42% lower (p < 0.01) com-
pared to the control group (Table 4).
However,  there  was  no  statistically  significant  difference 
between the OVX and MP groups and the control group, except 
for the maximum load in the MP group (–19%, p <  0.05).
Discussion 
Rabbits  have  an  active  Haversian  remodeling  and  achieve 
skeletal maturity quickly (Gilsanz et al. 1988). Ovariectomy 
and corticosteroid administration are the main treatments for 
establishment  of  experimental  osteoporosis  models  in  rab-
Table 1. Body weight (in kg) of the rabbits over the course of the study
Group  Baseline  Time after surgery 
  (before surgery)  2 weeks  6 weeks  10 weeks
Sham control  4.09 (0.25)  4.13 (0.23)  4.11 (0.20)  4.11 (0.20)
OVX  4.29 (0.37)  4.25 (0.33)  4.35 (0.33)  4.38 (0.30)
MP  4.15 (0.23)  4.18 (0.21)  4.13 (0.20)  4.14 (0.23)
OVX+MP  4.20 (0.31)  4.19 (0.29)  4.25 (0.27)  4.28 (0.30)
Values are mean (SD).
OVX: bilateral ovariectomy; MP: methylprednisolone.
Table 2. Variations in bone mineral density (BMD, mg/cm2) in rabbit lumbar spine with respect 
to baseline conditions and 6 and 10 weeks after intervention: OVX and/or methylprednisolone 
succinate (MP) administration
  Baseline  6 weeks after surgery  10 weeks after surgery
Groups  BMD  BMD  ΔBMD [%]  BMD  ΔBMD [%]
Sham control  304 (39)  294 (30)  –10 (9) [–3.4]  307 (40)        3 (6) [1.0]
OVX  293 (31)  274 (23)  –19 (17) [–6.5]  268 (22)    –25 (24) [–8.5]
MP  296 (37)  267 (25)  –30 (23) [–9.9]  231 (33)    –65 (58) [–22] a
  OVX+MP  297 (36)  250 (23)  –46 (28) [–16] a  189 (12)  –107 (26) [–36] b
BMD values (mg/cm2) are mean (SD). ΔBMD means variations in BMD 6 or 10 weeks after 
intervention. Values in square brackets represent the percentage of change from baseline.
a p <0.05) and b p <0.001 compared to sham control group.Acta Orthopaedica 2010; 81 (3): 396–401  399
bits (Grardel et al. 1994, Southard et al. 2000, Eberhardt et 
al. 2001), but the induction of OP by any of these methods 
alone has been controversial. In our study, isolated OVX for 
10 weeks did not induce adequate reduction of the BMD. 
This is in accordance with previously reported results (Mori 
et al. 1997, Turner et al. 2001), and suggests that the rabbit 
is a poor model for ovarian deprivation osteoporosis. Since 
a  few  reports  have  indicated  that  systemic  corticosteroids 
at high dose may result in cartilage damage and even death 
(Warman and Boskey 1983, Grardel et al. 1994), we chose 
a dose of 1mg/kg/day that has been found to have an effect 
on bone turnover without any additional detrimental effects 
(Eberhardt et al. 2001, Castaneda et al. 2008). At the same 
time, we tested the combination of ovariectomy and cortico-
steroid treatment to assess whether a more consistent model of 
osteoporosis could be established in this way. To our knowl-
edge, no authors have reported an adequate reduction in BMD 
in rabbits according to the WHO criteria for osteoporosis in 
humans (Lill et al. 2002). Human osteoporosis is defined as 
a reduction in BMD of more than 2.5 SD, which is approxi-
mately 25%. In this study, OVX+MP induced a decrease in 
BMD of about 36%.
Rabbits become sexually mature between 20 and 24 weeks 
of age and reach skeletal maturity at 28–32 weeks (Wang et al. 
2006). The peak bone mass occurs at 32–36 weeks (Gilsanz et 
al. 1988, Norris et al. 2001) and regular bone resorption and 
formation is well established at this stage. In our study, the bone 
mass in sham control rabbits remained stable, indicating that in 
contrast to other rodents, rabbits can reach true skeletal maturity.
Table 3. Bone microarchitecture parameters of the lumbar vertebrae (micro-CT data) after the 10-week interventions. Values are 
mean (SD)
Groups  Trabecular  Trabecular  Trabecular  Bone volume/  Bone surface area/  Connectivity
  number  thickness  separation  total volume  bone volume  density
  (1/mm)  (mm)  (mm)  (%)  (1/mm)  (1/mm3)
Sham control  1.69 (0.24)  0.21 (0.03)  0.38 (0.07)  0.36 (0.03)    9.4 (1.6)  7.0(1.3)
OVX  1.74 (0.25)  0.19 (0.02)  0.39 (0.08)  0.36 (0.05)  10 (1.9)  6.6 (1.2)
MP  1.64 (0.37)  0.17 (0.02) a  0.45 (0.13)  0.30 (0.04) a  12 (2.6)  5.6 (1.5)
OVX+MP  1.28 (0.16) a  0.14 (0.02) c  0.60 (0.16) b  0.22 (0.03) c  14 (2.9) b  4.5 (0.55) b
a p <0.05), b p <0.01), and c p <0.001 compared to the sham control.
Figure 2. Three-dimensional reconstructions by micro-CT from lumbar 
vertebra of a sham control rabbit (panel a), a rabbit from the OVX 
group (panel b), a rabbit from the MP group (panel c), and a rabbit 
from the OVX+MP group. For data, see Table 3.
Table 4. Mechanical parameters of lumbar vertebrae after the 10-week interven-
tions. Values are mean (SD)
Group  Maximum load  Displacement  Stiffness  Energy
  (N)  (mm)  (N/mm)  (mJ)
Sham control  1212 (153)  1.32 (0.36)  1091 (167)  850 (177)
OVX  1041 (111)  1.46 (0.39)    949 (190)  810 (91)
MP    984 (161) a  1.28 (0.20)    838 (164)  696 (102)
OVX+MP    735 (87) c  1.18 (0.24)    653 (204) b  496 (73) b
a p <0.05), b p <0.01), and c p <0.001 compared to the sham control.400  Acta Orthopaedica 2010; 81 (3): 396–401
High-resolution  micro-computed  tomography  (micro-CT) 
can be used to measure both the quantity and quality of tra-
becular  bone  (Mittra  et  al.  2008).  In  our  study,  the  lower 
BMD found in the lumbar vertebrae of the MP group and 
the OVX+MP group was reflected by structural changes in 
the high-resolution micro-CT image. The micro-CT analysis 
showed that the bone volume fraction (BV/TV) and the tra-
becular thickness in the MP-group rabbits decreased as com-
pared to the sham control animals. All structural parameters 
(Tb.N, Tb.Th, Tb.Sp, BV/TV, BS/BV, Conn.D) of the lumbar 
vertebrae in OVX+MP-group rabbits had statistically signifi-
cant differences compared to the control group, suggesting 
that microarchitectural deterioration of the lumbar vertebrae 
had occurred in the rabbits.
Compression testing of lumbar vertebrae is recommended 
for  testing  the  mechanical  properties  of  cancellous  bone 
(Adinoff  and  Hollister  1983).  Maximum  load  is  a  widely 
used  parameter  for  mechanical  evaluation,  and  represents 
the maximum force that a material can sustain before failure. 
Displacement, stiffness, and energy absorption capacity are 
also important (Peng et al. 1994, Gurgul et al. 2008). Bone 
fragility can be defined by mechanical parameters, including 
maximum load, displacement, and energy absorption (Turner 
2002). In the present study, we found that maximum load 
and stiffness were reduced in the OVX+MP group (Table 4), 
indicating that induction by OVX and MP for 10 weeks could 
reduce bone strength. Displacement was reduced by 10% in 
the OVX+MP group, although no statistically significant dif-
ference was found. The energy absorption capacity (work to 
fracture) of the OVX+MP group was reduced relative to the 
control group. These results suggest that bone fragility was 
increased and that the bone was more susceptible to fracture 
in the OVX+MP group. 
In the rabbit study of Castaneda et al. (2008), the BMD 
of the lumbar vertebrae decreased by 17% from baseline at 
6 weeks. In our study, a longer induction time was used and 
we found a decrease in BMD of about 36%. Our modified 
rabbit model is characterized by low bone mass and microar-
chitectural deterioration in bone tissue, with impaired skeletal 
strength and increased susceptibility to fracture.
The search for an experimental model of osteoporosis will 
continue as long as there are discrepancies between the results 
in humans and in potential models. Our model of osteoporosis 
in rabbits, induced by a combination of OVX and glucocorti-
coid administration, has several advantages over other animal 
models, as it is a model in a skeletally mature mammal that is 
easy to obtain and care for, and the induction procedure is rel-
atively short and uncomplicated, with a high degree of repro-
ducibility. In addition, we believe that it would be more appro-
priate to involve BMD, bone microarchitecture, and mechani-
cal parameters in evaluation of models of osteoporosis. 
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